NCT00917280

Brief Summary

The overall purpose of this research is to learn how Parkinson's disease affects thinking and memory in everyday life. Participation will involve thinking tests, questionnaires and interviews about thinking and activities in everyday life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
174

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2008

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2008

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 8, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 10, 2009

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

June 3, 2015

Status Verified

June 1, 2015

Enrollment Period

5.6 years

First QC Date

June 8, 2009

Last Update Submit

June 1, 2015

Conditions

Parkinson's Disease

Keywords

Parkinson's Disease

Study Arms (2)

Parkinson's Disease

Parkinson Disease participants without dementia

Control

Non-PD participants, matched for age, education and gender.

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Controls: Recruited from community, VFH.

You may qualify if:

  • WUSM Movement Disorders Clinic patients
  • males or females between 40 and 70
  • meet criteria for idiopathic typical PD
  • classified at Hoehn \& Yahr12 stage I, II, or III
  • are currently treated with levodopa/carbidopa
  • The groups will be matched for age, education and gender
  • No Parkinson Disease

You may not qualify if:

  • suspected dementia
  • treatment with certain dopaminergic, anticholinergic or benzodiazepine medications
  • other neurological problems
  • brain surgery
  • history or current psychotic disorder
  • any condition which would interfere with testing
  • control only: a biological family history of PD and being a caregiver or spouse of someone who has PD

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Erin Foster

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Occupational Therapy, Neurology and Psychiatry

Study Record Dates

First Submitted

June 8, 2009

First Posted

June 10, 2009

Study Start

December 1, 2008

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

June 3, 2015

Record last verified: 2015-06

Locations

US(1)